Abstract: Pregnant rats were administered flutamide at a daily dose of 10 mg/kg from gestation day 12 (GD12) to GD21, or 30 mg/kg on 2 successive days in the period from GD14 to . The effects on ventral prostate in male offspring were examined by RT-PCR on postnatal day 1 (PND1) for the 10 mg/kg group, and by receptor binding assay at PND76 or 78 and morphologically at PND7, 14, and 21 for all groups. RT-PCR demonstrated increase in mRNAs for the androgen receptor (AR) and the keratinocyte growth factor (KGF), but not transforming growth factor (TGF)-beta1 and beta2, the epidermal growth factor receptor (EGFR), and the vascular endothelial growth factor (VEGF). Prostate tissue showed a consistent reduction in the number of main ducts and ductal branchpoints, as well as the complexity of the terminal ductal network in the 10 mg/kg group, and the 30 mg/kg GD16-17 and GD18-19 groups. The effect on ductal architecture was severest with the 10 mg/kg regimen. The organ weights at PND76 or 78 were reduced in all flutamide treated groups. The value for the 10 mg/kg group was lowest, while the 30 mg/kg GD14-15 and GD20-21 groups were least affected. Receptor binding assays exhibited no significantly difference regarding maximum binding capacity (Bmax) and dissociation constant (Kd) between the control and any flutamide treated group. In conclusion, prenatal exposure to flutamide caused increased AR and KGF mRNA expression just after exposure, and an irreversible morphological change that is severest when the prostatic buds are developing in the ventral prostate. However the receptor binding capacity later in life was not affected. (J Toxicol Pathol 2003; 16: 237-245) 
Introduction
Androgen regulates male sexual differentiation and reproductive development. In particular, during the perinatal period when sexual differentiation occurs, androgen levels are very low but very important. Exposure to anti-androgenic compounds during this critical phase can cause various sexual aberrations in male animals, including a reduced ano-genital distance (AGD), nipple retention, undevelopment reproductive organs, hypospadias, cryptorchidism, cleft phallus, vaginal pouch, and decreased sperm production [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] .
Perinatal exposure to anti-androgen undoubtedly affects the development of accessory genital organs in male pups, and morphological abnormalities found in neonates are likely to be irreversible. However, it has remained controversial whether all the effects, including those on morphology and function, are actually irreversible. There have appeared reports describing effects of perinatal exposure to anti-androgens on subsequent responsiveness to androgens or anti-androgens [13] [14] [15] . Furthermore, other studies have revealed change of immunohistochemicallydemonstrable androgen receptor (AR) or nuclear AR concentrations in testis or prostate in adulthood after exposure to estrogenic or anti-androgenic compounds perinatally or prenatally 2, 7 . Among the androgen dependent organs, the ventral prostate is the most sensitive to male sex steroids 16 . There is regional specificity in the sensitivity to androgens or the reactions after castration [17] [18] [19] . In the prostate, androgens act via mesenchymal AR to elicit synthesis and secretion of various autocrine and paracrine factors that regulate epithelial and stromal growth and differentiation 20, 21 . The epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), KGF, and insulin-like growth factor (IGF) can all stimulate growth of prostatic epithelial cells. In contrast, TGF-beta has been shown to exert inhibitory effects on prostatic stromal and epithelial cells 20, 21 . Furthermore, vascular endothelial growth factor (VEGF) is up-regulated in vitro and in vivo by androgens in the adult rat 22 . Most of these growth factors detected during the perinatal period vary in their level until the adult stage, and are up-or down-regulated by androgens.
Reports describing the effects of sex hormone imbalance on prostatic detail morphogenesis have been limited, especially regarding the rat prostate, whose prostate architecture features are very complicated ductal arborization and are very different from those of mice 23, 24 . According to Bentvelsen et al. 25 , prenatal exposure to flutamide, a pharmaceutical product having androgen receptor antagonistic activity, causes a reduction in density and frequency of androgen receptor positive cells in the rat fetal urogenital tract where prostate duct buds arise. Donjacour and Cunha castrated neonatal mice within 24 hr of birth, and showed that the prostate demonstrated decreased wet weight and numbers of ductal tips and branch points, androgen supply reversing the change in these parameters 26 . In addition, Donjacour and Cunha reported that when the supply was delayed, recovery was only noted for the wet weight 26 . In the present study, we tried to clarify the main factor with respect to the irreversible effects, which might be related to the altered responsiveness to androgen later in life, after exposure to anti-androgen prenatally. We employed flutamide as a typical anti-androgen, which is often used as a positive control in anti-androgen screening tests. The microdissection technique introduced by Hayashi et al. 23 was employed to examine prostate morphogenesis. Ductal morphogenesis and branching patterns have been detailed for rats and mice [17] [18] [19] 23, 24, 27 . In addition, we carried out RT-PCR using neonatal prostate tissue, focusing in the many growth factors established to contribute to prostate morphogenesis. Furthermore, to cast light on altered responsiveness to androgens, effects on receptor function later in life were investigated.
Materials and Methods

Experimental animals
All experiments were performed in accordance with The Guide for Animal Care and Use of Sumitomo Chemical Co., Ltd.
A total of 28 Crj:CD (SD) IGS (SPF) female rats at gestation Day 3 (GD3) were purchased from Charles River Japan Inc. (GD0 means the day sperm were detected in vaginal smears.) and individually housed in suspended aluminum cages with a stainless-steel wire-mesh front and floor under controlled environmental conditions, including a temperature of 22-26°C, a relative humidity of 40-70%, a frequency of ventilation of more than 10 air exchanges/hr, and a 12-hr light/12-hr dark cycle (lighting period, 0800-2000). From GD21 until weaning, the front of each cage was covered with a stainless steel partition plate, and each cage was provided with a parturition tray containing 'Alfa-dry' bedding (Shepherd Specialty Papers, Inc., Japan). Animals were provided CRF-1 diet (Oriental Yeast, Co., Ltd., Japan) through the pregnancy and lactation periods, and after weaning. Drinking water and pellet rodent diet were available ad libitum.
Dams were administered flutamide (Sigma Chemical Co., Ltd., USA) in 0.5% carboxymethylcellulose by gavage at doses of 0, 10, and 30 mg/kg. Ten mg/kg is a dose level causing decrease in prostate size, and 30 mg/kg causes aplasia in almost all perinatally exposed animals to flutamide (preliminary study data not shown). Control animals received the vehicle only (5 ml/kg/day) from GD12 to 21. Dams of the 10 mg/kg group were administered the daily dose from GD12 to 21. Their counterparts in the 30 mg/kg group were assigned to 4 subgroups and administrated the compound on 2 successive days: GD14-15, GD16-17, GD18-19 or GD20-21, with the vehicle given on the other days. For the control and the 10 mg/kg groups, 8 dams were allocated, while 12 animals were used for the 30 mg/kg group (3 animals for each subgroup). Dam body weights were measured from GD3 to PPD21, every 2 or 3 days during gestation and weekly during lactation, and clinical signs were recorded daily.
Following delivery of entire litters (PND0), the numbers of live pups were counted, and clinical signs and mortality were recorded. Pups' body weights were measured at PND2, 6, 13, and once a week subsequently and they were examined for clinical signs daily. Because the recognition of sex in affected pups was impossible without necropsy, the proportions of males/females and other data for each sex were estimated after sacrifice.
RT-PCR
Ventral prostate tissue of each of 5 pups from the control and 10 mg/kg groups was dissected at PND 1 after exsanguination under CO 2 anesthesia. All pups were from different mothers. Total RNA was isolated from prostate tissues frozen in liquid nitrogen using ISOGEN (Nippon Gene, Tokyo, Japan) and RT was performed with a TAKARA PCR kit (AMV) Version 2 (Takara Shuzo, Osaka, Japan). Real time PCR was performed semi-quantitatively for AR, TGF-beta1, beta2, KGF, EGFR, and VEGF, according to the protocol supplied for the ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Chiba, Japan) with minor modifications in accordance with our preliminary experiments. The primer and probe sequences employed for RT-PCR were designed according to the guidelines stated in the protocol. They are listed in Table 1 .
PCR was performed with 25 µl of reaction mixture using a Taqman Universal Master Mix (Applied Biosystems, Chiba, Japan). Each reaction was performed 3 times to confirm reproducibility, and the mean value was obtained. The relative volume was generated from data for beta-actin as an internal control.
Prostatic branching morphogenesis
Ventral prostate tissue was dissected from one male pup per dam at PND7, 14 and 21 after exsanguination under CO 2 anesthesia. The microdissection method was in accordance with the technique introduced by Hayashi et al. 23 . Briefly, after sacrifice the ventral prostate was excised and transferred to calcium-and magnesium-free phosphate Hanks' Balanced Salts solution (Santa Ana, California) at 4°C. After trimming off surrounding adipose tissue and the capsule carefully, dissection was performed in solution containing 0.25% collagenase at room temperature. All the procedures were performed under a stereomicroscope (STZ zoom, Olympus Optical, Tokyo, Japan) using fine forceps and a von Graefe iris knife.
Ventral prostate weight
At PND 76 or 78, all the remaining male pups were killed by decapitation. After necropsy, the ventral prostate tissue was dissected and weighted. Because approximately half of the animals in the 10 mg/kg group exhibited severe hypoplasia, their tissues were not weighed or used for the following analyses. The numbers of prostates weighed for the control, 10 mg/kg and 30 mg/kg groups (GD14-15, 16-17, 18-19, 20-21) were 20, 12, 30 (9, 7, 10, and 4), respectively.
Androgen receptor binding assay
[17α-methyl-3 H]-methyltrienolone (R1881; 83.5Ci/ mmol) and radioinert R1881 were purchased from PerkinElmer Life Sciences (Boston, U.S.A.) and Hydroxylapatite (Bio-Gel HT) from Bio-Rad (Richmond, U.S.A.).
The numbers of ventral prostates used for the control, 10 mg/kg and 30 mg/kg groups (GD14-15, 16-17, 18-19, 20-21) were 8, 10, 26 (6, 7, 9 and 4), respectively. The numbers of samples were 8, 2, 25 (6, 6, 9, and 4), because tissues of multiple animals (2-5) were needed when the weights of tissues were low.
The prostate tissues were immersed in ice-cold TEDG buffer [10 mM Tris, 1.5 mM EDTA, 10% glycerol (v/v), and 1 mM each of dithiothreitol, phenylmethylsulfonyl fluoride, and sodium molybdate; pH 7.4] and then homogenized on ice (1g tissue/5 ml buffer) with 10-sec bursts of a polytron. The homogenate was centrifuged at 30,000 g for 30 min and the supernatant containing the unoccupied cytosolic receptors was removed. It was not used for the analysis because of low binding values. The pellet was homogenized at 15 min intervals for 1 hr in high-salt buffer (TEDG buffer with 0.4 M KCl) and centrifuged as before. This resultant supernatant (the high salt extract) contained nuclear 
Statistical analysis
All results except for the numbers of main ducts were tested with the F test 31 for statistically significant differences between the control and flutamide groups. When not significant, a Student's t test 31 was performed. When significant, an Aspin-Welch test 3 1 was conducted. Concerning the number of main ducts, a Mann-Whitney Utest 32 was carried out. Significant differences from the control group were estimated at probability levels of 1 and 5%.
Results
Dams and pups
There were no differences in body weight and body weight gain regarding dams and pups. Dams did not exhibit any abnormal clinical signs throughout the pregnancy and lactation periods and all were delivered at GD22 or 23. Abnormal signs were not detected except for effects on the external genitalia (data not shown). Figure 1 shows the results of semiquantitative RT-PCR for the control and 10 mg/kg pups at PND 1. There was a considerable increase with statistically significance in AR and KGF mRNAs with the 10 mg/kg treatment. Regarding TGF-beta1 and beta 2, EGFR and VEGF, however, there was no significant variation.
RT-PCR
Prostatic branching morphogenesis
The control ventral prostate comprises paired right and left lobes (Figs. 2a-c) . Both lobes are composed of 2-3 main ducts arising from the ventral aspect of the bladder neck. At PND 7, the control prostate was already so extensively branched that it was not possible to accurately assess the ductal branching. There were apparently 3-5 ductal branchpoints between the main ducts and the terminal ducts, the latter forming the peripheral arborizing ductal network of approximately 150 micrometers in length from the distal end. At PND14 and 21, the control prostate had become more complex.
On the other hand, the prostates from the 10 mg/kg group demonstrated reduced numbers of main ducts and ductal branchpoints, as well as decrease in the complexity of the terminal ductal network (Figs. 3a, b) . The degree of changes was wide-ranging, from complete aplasia to retention of an almost normal architecture. Some animals showed aplasia unilaterally and hypoplasia in the other lobe. The terminal ducts were short and narrow and less complex than in the controls. With 30 mg/kg, the GD14-15 and GD20-21 subgroups exhibited no morphological differences on stereomicroscopy, compared to the control, while the GD16-17 and GD18-19 groups demonstrated reduced numbers of main ducts, and short terminal ducts. At PND14 groups also demonstrated development, the numbers of main and secondary duct continued to be reduced and the ducts were narrow. Reduced numbers of main ducts were recognized in the 10 mg/kg and 30 mg/kg GD16-17 and GD18-19 groups, compared with the controls (Fig. 4) . Effects on the number of main ducts were severer with 10 mg/kg than in the subgroups receiving 30 mg/kg. Furthermore, the 30 mg/kg GD20-21 group showed significant decrease only at PND21.
Prostate weight
The ventral prostate weights at PND76 or 78 are summarized in Fig. 5 . All the groups exposed prenatally to flutamide demonstrated reduced organ weights. The value for the 10 mg/kg group was lowest, the 30 mg/kg GD14-15 and GD20-21 groups being less affected. Animals showing completely aplasia were excluded from the numbers examined in the 10 mg/kg group.
Androgen receptor binding assay
Androgen binding was demonstrated in high-salt extracts (occupied receptors) of ventral prostate. Saturation was reached near 20 nM R1881 (Fig. 6) . The observed affinity of R1881 binding (Kd = 2.0 nM) was comparable to the values previously reported 28, 30, 33 .
Maximum binding capacity (Bmax) and dissociation constant (Kd) in the extracts of rat ventral prostate in the control and flutamide treated groups were not significantly different (Fig. 7) .
Discussion
The rat prostate begins to develop late in gestation, when the urogenital sinus mesenchyme induces epithelial budding from the urogenital sinus epithelium 23, 24 . In the urogenital sinus, AR positive cells appear on fetal day (FD) 16, and are much more frequent at FD18 25 . According to Timms et al. 2 4 , the earliest indication of prostatic morphogenesis in rats is the appearance of small ventral epithelial outgrowths in the caudal aspect of the urogenital sinus on FD18. The rudiments of the ventral prostate are unbranched main ducts with thickened stroma. Hayashi et al. reported detailed morphogenesis in neonatal rats 23 . During PND1-5, additional main ducts arise from the urethra, so the ventral prostate consists of 2-3 main ducts per side. The ventral prostate is already very extensively branched at PND10, and the ductal branching pattern is nearly complete at PND30. In the present study, the control prostates were the same as Hayashi et al. reported earlier 23 . Exposure to flutamide prenatally clearly caused an abnormal architecture in neonatal animals, effects being found the most sensitive period to be GD18-19 during the fetal period (GD12-21) when GD1 was defined as the day sperms were detected (corresponding with GD17-18 in the present study in which GD0 was counted as the day sperms were detected), with exposure to vinclozolin, a fungicide having an antiandrogen character 9 . Our results are generally in line with their data. Considering that prostatic morphogenesis begins at GD18, the most sensitive period might be just at or before the time when the prostate buds are arising from the urethra. Here, exposure to flutamide on GD14-15 or 20-21 had little influence. Though the GD20-21 group showed significant decrease in the number of main ducts, this was only at PND21, and was considered to be incidental. Because there was no difference at PND7 and 14 compared to the control, reduction in the number of main duct with age is not plausible. There was limited to slight decrease in organ weight as compared to the controls. Because there might have been slight morphological differences regarding ductal branching, ductal diameter or length, which we could not recognize using a stereomicroscope, we must bear in mind that further examinations are needed for definitive conclusions to be drawn.
In the neonatal prostate, DNA synthetic activity is highest at the distal ductal tip, and considerably lower in proximal ducts near the urethra, and widely varies on castration or androgen treatment in the distal tip 19 . Sugimura et al. reported that prostatic regression begins at the distal tips near the prostatic capsule in adult mice 19 . Androgenic sensitivity for ductal morphogenesis is heterogeneous, and the most active region of DNA synthesis is most sensitive to anti-androgens. The present study revealed a reduced number of main ducts, which then remained unchanged in postnatal life. Thus, it was suggested that the number of proximal ducts directly reflects reduced organ weight though one's whole life, and branching changes might be attributable to altered responsiveness to androgen.
In the morphogenesis of prostate branching, many growth factors have been implicated. Androgens act via mesenchymal androgen receptors to elicit synthesis and secretion of various autocrine and paracrine factors that r e g u l a t e e p i t h e l i a l a n d s t r o m a l g r o w t h a n d differentiation 20, 21 . RT-PCR using tissues at PND 1 in the present study demonstrated increased mRNAs for AR and KGF, but not TGF-betas, EGFR, and VEGF. Increased AR mRNA is probably due to the increased ligand stimulation with flutamide. Serum testosterone levels are increased at PND4 after flutamide treatment 34 . In addition, in adult rats, increased AR mRNA just after exposure to an anti-androgen was earlier reported 35 . Concerning KGF, this stimulates prostate growth including ductal branching, the effects being blocked by anti-androgen 36 . According to Thomson et al. , KGF mimics androgen action, and anti-androgens are able to block KGF stimulated development, suggesting that KGF and AR signalling pathways may interact 3 7 . Like testosterone and AR mRNA, KGF mRNA might increase after flutamide exposure. However, it is highly likely that the increased KGF mRNA might reflect an alteration in the mesenchymal/epithelial ratio, because KGF is expressed in mesenchymal but not epithelial cells 37 . The mesenchymal/ epithelial ratio was clearly much higher in flutamide treated animals than in the controls. On the other hand, contrary to our expectation, TGF-beta1, 2, EGFR and VEGF mRNAs were not affected. This may have been due to the relatively late sampling of prostate tissue. At PND1, 2 days had already passed after the final administration. According to Itoh et al., TGF-beta suppresses ductal branching morphogenesis in response to androgen in prostate tissue culture at PND0, while TGF-beta1 and beta 2 mRNAs are increased after castration at PND60 38 . EGFR mRNA is already detectable at PND1, and increased after castration or decreased by testosterone, as with TGF-beta1 and beta 2 39 . Concerning VEGF, there is a report of up-regulation in vitro and in vivo by androgens 22 . With respect to the unchanged mRNAs found here, further studies are necessary for clarification.
With the present androgen receptor binding assay, we examined only occupied receptors, because unoccupied cytosolic receptors were expected to be below the limits of detection in all groups. Though Kelce et al. could demonstrate cytosolic receptors in the epididymides, the samples were from castrated animals 30 . RT-PCR at PND1 here revealed an increase in the AR mRNA expression, but androgen receptor binding assays did not confirm any differences. This suggests that the influence of prenatal exposure to flutamide does not persist as a receptor functional disturbance in the adult.
From the present results, we can conclude that prenatal exposure to flutamide, a typical anti-androgen, causes increased AR and KGF mRNA expression in the ventral prostate just after exposure. Morphological change is severest when exposure occurs in the period when the prostatic buds are rising and once the architecture is disturbed, this becomes permanent. However, receptor binding capacity later in life is not affected.
